Nano Covax COVID-19 vaccine candidate to be assessed by Indian institute

Theo NDO 04:06 24/09/2021 - Brand name drugs
The Translational Health Science & Technology Institute (THSTI) will evaluate immunogenicity of the Made-in-Vietnam Nano Covax COVID-19 vaccine candidate developed by Nanogen Pharmaceutical Biotechnology of Vietnam.
Vaccine Nano Covax (Source: Nanogen)
Vaccine Nano Covax (Source: Nanogen)

 

A memorandum of understanding to this effect was signed at a ceremony held in Faridabad city of India’s Haryana state on September 23.

Under the agreement, Nanogen will send cell samples of volunteers participating in the third trial phase of Nano Covax to the THSTI for assessment.

Vietnamese Ambassador to India Pham Sanh Chau affirmed that the collaboration with the THSTI holds significant meaning for Nanogen in the research and development of the vaccine candidate.

The Indian institute’s objective evaluation will help confirm the quality of Nano Covax and serve as a foundation for Nanogen to produce the homegrown COVID-19 vaccine for domestic use as well as for export.

THSTI is an institute of the Department of Biotechnology at the Ministry of Science and Technology of India. It has taken part in various vaccine development, assessment and trials in the country.

Nanogen is working with relevant Vietnamese agencies to step up trials of the vaccine candidate so that it will soon receive approval for emergency use in Vietnam.

 

Continuous reading

Health ministry official caught in Covid test kit scam

Health ministry official caught in Covid test kit scam

Brand name drugs - 26/05/2022

Health ministry official caught in Covid test kit scam

Vietnam to import Covid-19 antibody drug Evusheld

Vietnam to import Covid-19 antibody drug Evusheld

Brand name drugs - 11/03/2022

Vietnam to import Covid-19 antibody drug Evusheld

Guidelines on using newly approved COVID-19 vaccines to be issued soon

Guidelines on using newly approved COVID-19 vaccines to be issued soon

Brand name drugs - 27/09/2021

Guidelines on using newly approved COVID-19 vaccines to be issued soon

Vaccination considered “golden key” for COVID-19 control

Vaccination considered “golden key” for COVID-19 control

Brand name drugs - 24/09/2021

Vaccination considered “golden key” for COVID-19 control

Moderna working on combination COVID-19 vaccine booster and flu shot

Moderna working on combination COVID-19 vaccine booster and flu shot

Brand name drugs - 10/09/2021

Moderna working on combination COVID-19 vaccine booster and flu shot

Bảng thống kê bệnh nhân nhiễm bệnh nCoV các quốc gia trên thế giới